Drug Screening
Our bioscientists work closely with you and your Chemistry, Computational Chemistry and DMPK teams to deliver carefully tailored, informative and efficient drug screening programs using state of the art equipment, to deliver fully characterised hit, lead and candidate series.
Our scientists can support your project through the provision of reliable, flexible and robust Iterative screening to accelerate your Design-make-test-analyse cycle. In addition, we can undertake tailored Mechanism of Action (MOA) studies to provide a deep understanding of your compounds engagement with the target to inform your compound progression and design strategies.